Qiao Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Left Ventricular

Pulmonary Arterial Hypertension

High Fat Diet Induced

Top Venues

The Journal of pharmacy and pharmacology

Basic & clinical pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Qiao Liu, Qingman Luo, Bin Zhong, Yingxin Xiong, Xueling Chen, Xiaohui Li
Preparation of the new peptide drug ACTY116-loaded in situ forming implants and evaluation of its efficacy in pulmonary arterial hypertension and right ventricular hypertrophy induced by SU5416/hypoxia in mice. Basic & clinical pharmacology & toxicology (2024)
Qiao Liu, Qingman Luo, Bin Zhong, Yingxin Xiong, Xueling Chen, Xiaohui Li
Preparation of the new peptide drug ACTY116-loaded in situ forming implants and evaluation of its efficacy in pulmonary arterial hypertension and right ventricular hypertrophy induced by SU5416/hypoxia in mice. Basic & clinical pharmacology & toxicology 135 (1) (2024)
Qingman Luo, Qiao Liu, Kecheng Tang, Bin Zhong, Shengqian Yang, Xiaohui Li
Phillyrin improves myocardial remodeling in salt-sensitive hypertensive mice by reducing endothelin1 signaling. The Journal of pharmacy and pharmacology 76 (6) (2024)
Qingman Luo, Qiao Liu, Kecheng Tang, Bin Zhong, Shengqian Yang, Xiaohui Li
Phillyrin improves myocardial remodeling in salt-sensitive hypertensive mice by reducing endothelin1 signaling. The Journal of pharmacy and pharmacology 76 (6) (2024)
Qingman Luo, Qiao Liu, Kecheng Tang, Bin Zhong, Shengqian Yang, Xiaohui Li
Phillyrin improves myocardial remodeling in salt-sensitive hypertensive mice by reducing endothelin1 signaling. The Journal of pharmacy and pharmacology (2024)